Sun Pharmaceutical Industries Limited is actively offering pharmaceutical products for dermatology, ophthalmology, and oncology across 100+ countries, including the US. Founded in 1983, their portfolio includes specialty medicines, generic medicines, and active pharmaceutical ingredients. This pharma company owns 41 technology-enabled manufacturing facilities. In FY2024–25, Sun Pharma reported consolidated revenue of ₹52,076 crore and adjusted net profit of ₹12,119 crore. Its workforce comprises Dilip Shanghvi (Executive Chairman), Kirti Ganorkar (Managing Director), Aalok Shanghvi (Chief Operating Officer) and 47,000+ employees.

Establishment:

1983 in Mumbai, Maharashtra, India

Website:

https://sunpharma.com

Company Listed On:

Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE)

Core Business:

Sun Pharmaceutical Industries Limited provides manufacturing and marketing of pharmaceutical products, including generic medicines, specialty medicines, and APIs.

Financial Performance:

The company has experienced a 140% growth in its share price over the last five years. However, their revenue is ₹52,578 crore, and their net income is ₹11,984 crore for FY 2024-25.

Future Outlook:

1. Product innovation
2. Expanding the range of specialty medicines and
3. New pharmaceutical product launch
4. Focusing on affordability, long-term investment, and global distribution

Disclaimer:

Unsold 70 publishes research-based articles, blogs, news, and company profiles to help readers understand businesses along with their future prospects. It will help you learn about the stock market and mutual funds. We research the companies as per our algorithm and find companies that need further research. However, the Sun pharmaceutical Industries Ltd company profile is not an investment recommendation, as past performance does not guarantee future results. You should perform your own research and seek advice from a SEBI-registered financial advisor before making investment decisions. Visit our latest news page to know about the current trends of this company. It will help you to take up the companies for further research.